Oh Boy . . . This is awkward.

We couldn't find the article you were looking for. Sorry.

We think the articles below are much more interesting.

Why not give them a shot?


The Top News
Display List: Hottest | Weekly Summary | Latest
Display Style: Full | Summary
3:45 PM - Friday, July 25, 2014
4 hour ago - Yahoo! News: Business News
MOSCOW (AP) — Nearly a quarter-century after McDonald's startled and delighted Soviets with their first taste of American fast-food culture, the company's now facing a suit that could ban it from selling some of its signature products.
4 hour ago - news / Andrew Trotman
A disastrous first day of trading, hampered by technical glitches and confused investors, meant underwriters had to step in and buy Facebook's stock
5 hour ago - CNBC
Goldman downgraded equities to "neutral" over the next three months, citing the risk of a temporary sell-off in stocks following a sell-off in bonds.
4 hour ago - MarketWatch.com
NEW YORK (MarketWatch) -- Tyson Foods Inc. on Friday said it's planning to close three facilities in Iowa, New York and New Mexico in the first half of 2015, in a move that will affect about 950 workers. In a statement, the meat-processing com . . .
4 hour ago - WSJ.com
Maternity-apparel retailer Destination Maternity Corp. dropped its bid to buy U.K.'s Mothercare PLC in what would have been the first U.S. retail chain to try using a controversial tactic to reincorporate overseas to lower its tax bill.
4 hour ago - Washington Post / Jiaxi Lu
Google is exploring the human body, hoping to develop a definition for a “healthy” person by cells and molecules. This ambitious project, which the company claims “has never been done before” and known as the Baseline Study, is being led by th . . .
7 hour ago - Money Supply blog on central banks
Fraud agency must pay the £3m in 14 days and has also agreed to pay £3m towards legal costs in the same timeframe
4 hour ago - WSJ.com
AbbVie Inc. said its second-quarter earnings rose as strong global sales of the drug maker's rheumatoid-arthritis drug Humira continued to boost results.
Untitled Page